查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2019264

全球術前皮膚準備市場：依最終用戶、產品類型、劑型、應用領域、通路及地區進行分析－市場規模、產業趨勢、機會分析及2026-2035年預測

Global Preoperative Skin Preparation Market: Analysis End User, By Product Type, Formulation Type, Application Area, Distribution Channel, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球術前皮膚消毒市場正快速擴張，反映出全球外科醫學界對感染預防和病人安全的日益重視。預計到2025年，該市場規模將達到13.102億美元，到2035年將達到21.665億美元。這一成長意味著在2026年至2035年的預測期內，複合年成長率約為5.16%。這種穩定上升的趨勢凸顯了對先進皮膚消毒產品和給藥系統投資的不斷增加，這些產品和系統對於降低手術部位感染（SSI）的發生率至關重要，而手術部位感染是所有醫療機構面臨的重大挑戰。

推動市場成長的主要因素之一是新興國家術前皮膚清潔方案的快速普及。在亞太地區、拉丁美洲和非洲部分地區，隨著醫療基礎設施的改善和手術量的增加，對有效感染控制產品的需求激增。在這些市場，人們越來越意識到手術部位感染（SSI）的臨床和經濟影響，促使醫院和手術中心優先考慮可靠的皮膚清潔通訊協定。

顯著的市場趨勢

術前皮膚消毒劑市場高度一體化，呈現寡占格局，由少數幾家實力雄厚的「一級」公司主導，這些公司佔據了大部分市場佔有率並製定了行業標準。在這些領導企業中，貝克頓·迪金森公司（BD）憑藉其廣受認可的ChloraPrep™產品系列，成為無可爭議的施用器之王。 BD的競爭優勢在於其創新且取得專利的施用器設計，該設計可有效防止液體滯留，這對於確保消毒劑的持續安全塗抹至關重要。

同時，3M的醫療保健業務（現已分拆為Solventum公司營運）憑藉其DuraPrep™和SoluPrep™產品線繼續發揮重要的市場影響力。儘管組織架構有所調整，但這些品牌在術前皮膚消毒領域依然是強大的競爭對手。 Solventum的優點在於其在聚合物化學領域的專業知識，這使得該公司能夠開發出可在皮膚上形成持久薄膜並有效殺死微生物的消毒劑。

Ecolab 和 Medline Industries 在大宗解決方案領域和醫院合約方面佔據主導地位，業務規模和分銷能力是決定性因素。特別是 Medline，它利用其廣泛的分銷網路，將皮膚消毒劑與定製手術托盤捆綁銷售，從而在門診手術中心 (ASC) 領域佔據主導地位。

主要成長要素

手術部位感染 (SSI) 的高發生率是推動術前皮膚清潔市場強勁成長的關鍵因素。 SSI 的發生率極高，約佔全球醫療相關感染 (HAI) 的 20%。如此高的發生率不僅嚴重威脅病患安全，還會顯著增加病患的發生率、延長住院時間並提高再入院率。 SSI 的廣泛影響凸顯了採取有效預防措施的迫切性，也使得先進的皮膚清潔技術成為醫療機構感染控制策略的核心。

新機會的趨勢

隨著術前皮膚清潔市場向2035年發展，最有價值創造前景的機會正湧現於材料科學與人工智慧（AI）的交叉領域。這種融合將徹底革新皮膚消毒方式，超越傳統的化學配方，並融入智慧技術，進而提升精準度、功效和病人安全性。將旨在提供卓越抗菌性能的先進材料與最佳化應用和監測的AI驅動系統相結合，預示著一個新時代的到來——一個真正意義上的「智慧」皮膚清潔時代。

最佳化障礙

氯己定（CHG）因其廣譜抗菌特性和已被證實能有效降低手術部位感染率，長期以來一直是術前皮膚清潔消毒劑的黃金標準。其在全球醫院和手術中心的廣泛應用，反映了其強大的療效和良好的安全性。然而，近期趨勢表明，氯己定使用量的增加與嚴重I型超敏反應（包括危及生命的過敏性休克）的發生率上升之間存在令人擔憂的關聯。雖然這些過敏反應相對罕見，但它們對病人安全構成重大風險，並正引起臨床醫生和監管機構的日益關注。

目錄

第1章執行摘要：全球術前皮膚科治療市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 按地區分類的主要調查受訪者組成
  • 本研究的前提
  • 市場規模估算
  • 數據檢驗

第3章：全球術前皮膚準備市場概覽

  • 產業價值鏈分析
    • 原料和活性成分的採購
    • 配方和生產
    • 經銷和供應鏈管理
    • 終端用戶消費和臨床應用
  • 產業展望
    • 10種常見皮膚病及治療方法[PY1.1]
  • PESTLE分析
  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭強度
  • 市場成長及前景
    • 市場收入估算與預測（2020-2035 年）
    • 按產品類型分類的價格趨勢分析

第4章：全球術前皮膚準備市場分析

  • 競爭格局概述
    • 市場集中度
    • 企業市場占有率分析（以金額為準，%），2025 年
    • 競爭對手分析與基準測試

第5章：全球術前皮膚準備市場分析

  • 市場動態和趨勢
    • 成長要素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測（2020-2035）
    • 依產品類型
      • 關鍵見解
        • 氯己定類產品
        • 優碘溶液
        • 酒精製劑
        • 消毒擦拭巾
        • 其他術前皮膚準備產品
    • 製劑形式
      • 關鍵見解
        • 水溶液
        • 形式
        • 凝膠
        • 噴
        • 預浸濕擦拭巾
    • 按應用程式字段
      • 關鍵見解
        • 一般外科
        • 整形外科手術
        • 心血管外科
        • 整形手術
        • 其他外科手術
    • 最終用戶
      • 關鍵見解
        • 醫院
        • 門診手術中心
        • 專科診所
        • 家庭醫療保健服務提供者
        • 研究機構
    • 透過分銷管道
      • 關鍵見解
        • 直銷
        • 藥局
        • 線上零售
        • 醫療用品商店
        • 銷售代理
    • 按地區
      • 關鍵見解
        • 北美洲
          • 美國
          • 加拿大
          • 墨西哥
        • 歐洲
          • 西歐
            • 英國
            • 德國
            • 法國
            • 義大利
            • 西班牙
            • 其他西歐國家
          • 東歐
            • 波蘭
            • 俄羅斯
            • 其他東歐國家
        • 亞太地區
          • 中國
          • 印度
          • 日本
          • 韓國
          • 澳洲和紐西蘭
          • ASEAN
              • 印尼
              • 馬來西亞
              • 泰國
              • 新加坡
              • 其他東協國家
          • 其他亞太地區
        • 中東和非洲
          • 阿拉伯聯合大公國
          • 沙烏地阿拉伯
          • 南非
          • 其他中東和非洲
        • 南美洲
          • 阿根廷
          • 巴西
          • 南美洲其他地區

第6章：北美市場分析

第7章：歐洲市場分析

第8章：亞太市場分析

第9章：中東和非洲市場分析

第10章：南美市場分析

第11章：公司簡介

  • 3M
  • B. Braun Melsungen
  • Baxter International
  • Betadine（Johnson &Johnson）
  • DuPont
  • Ecolab
  • Essity
  • GAMA Healthcare
  • Hibiclens（Molnlycke Health Care）
  • Kimberly-Clark
  • Medline Industries
  • Precept Medical Products
  • Smith &Nephew
  • SurgiCare
  • Theradome

第12章附錄

簡介目錄
Product Code: AA03261723

The global preoperative skin preparation market is experiencing rapid expansion, reflecting the growing emphasis on infection prevention and patient safety in surgical care worldwide. Valued at USD 1,310.2 million in 2025, the market is projected to reach an impressive USD 2,166.5 million by 2035. This growth represents a compound annual growth rate (CAGR) of approximately 5.16% during the forecast period from 2026 to 2035. The steady upward trajectory highlights increasing investments in advanced skin antiseptic products and delivery systems that are critical to reducing the incidence of surgical site infections (SSIs), which remain a major challenge across healthcare settings.

A key driver behind this market growth is the accelerated adoption of preoperative skin preparation solutions in emerging economies. As healthcare infrastructure improves and surgical volumes rise in regions such as Asia-Pacific, Latin America, and parts of Africa, there is a corresponding surge in demand for effective infection control products. These markets are witnessing increased awareness about the clinical and economic consequences of SSIs, prompting hospitals and surgical centers to prioritize reliable skin preparation protocols.

Noteworthy Market Developments

The market for preoperative skin preparation is highly consolidated, operating as an oligopoly dominated by a handful of powerful "Tier 1" companies that control the majority of market share and set industry standards. Among these leaders, Becton, Dickinson and Company (BD) stands out as the undisputed king of the applicator segment, primarily through its widely recognized ChloraPrep(TM) product portfolio. BD's competitive moat is built on innovative patented applicator designs that effectively prevent fluid pooling, which is crucial for ensuring consistent and safe application of antiseptics.

In parallel, 3M's healthcare business, now operating under the spin-off company Solventum, continues to exert significant influence with its DuraPrep(TM) and SoluPrep(TM) product lines. Despite the organizational changes, these brands remain formidable competitors within the preoperative skin preparation landscape. Solventum's strength lies in its expertise in polymer chemistry, which enables the creation of antiseptic solutions that form a durable microbial-locking film on the skin.

Ecolab and Medline Industries occupy a dominant position in the bulk solution segment and hospital contracting space, where the scale of operations and distribution capabilities are decisive factors. Medline, in particular, leverages its expansive distribution network to bundle skin preparation solutions with custom surgical trays, making it a dominant force in the ambulatory surgical center (ASC) tier.

Core Growth Drivers

The epidemic of surgical site infections (SSIs) stands as a critical driver behind the robust growth of the preoperative skin preparation market. SSIs are alarmingly prevalent, accounting for nearly 20% of all healthcare-associated infections (HAIs) worldwide. This high incidence not only poses a significant threat to patient safety but also contributes extensively to increased morbidity, prolonged hospital stays, and elevated readmission rates. The widespread impact of SSIs underscores the urgent need for effective preventive measures, positioning advanced skin preparation technologies at the forefront of infection control strategies within healthcare settings.

Emerging Opportunity Trends

As the preoperative skin preparation market advances toward 2035, the most exciting opportunities for value creation are emerging at the crossroads of material science and artificial intelligence (AI). This convergence is set to revolutionize the way skin antisepsis is approached, moving beyond traditional chemical formulations to incorporate intelligent technologies that enhance precision, efficacy, and patient safety. The integration of advanced materials engineered for superior antimicrobial performance with AI-driven systems capable of optimizing application and monitoring marks the dawn of a new era-one that can be aptly described as the era of "Smart" Skin Preparation.

Barriers to Optimization

Chlorhexidine (CHG) has long been regarded as the gold standard in antiseptic formulations for preoperative skin preparation due to its broad-spectrum antimicrobial properties and proven effectiveness in reducing surgical site infections. Its widespread adoption across hospitals and surgical centers worldwide reflects its strong efficacy and established safety profile. However, recent trends have highlighted a concerning correlation between the rising usage of chlorhexidine and an increase in severe Type I hypersensitivity reactions, including life-threatening anaphylaxis. These allergic reactions, although relatively rare, pose significant risks to patient safety and have drawn heightened attention from both clinicians and regulatory authorities.

Detailed Market Segmentation

By formulation, pre-filled applicators have become a dominant force in the preoperative skin preparation market, now capturing over 50% of the market's total value. This significant market share reflects a growing preference among healthcare providers for these ready-to-use delivery systems, which offer a combination of convenience, precision, and safety that traditional formulations cannot easily match. Pre-filled applicators eliminate the need for manual mixing or measurement of antiseptic solutions, reducing the risk of contamination and dosing errors, which is critical in maintaining stringent infection control standards in surgical environments.

By End Users, the landscape of surgical care has undergone a significant transformation, with traditional acute-care hospitals no longer serving as the sole epicenter of surgical volume. This shift is largely driven by remarkable advances in minimally invasive surgery (MIS) and robotic-assisted techniques, which have expanded the scope and complexity of procedures that can be safely and effectively performed outside conventional hospital settings. These technological innovations have made it possible to conduct sophisticated surgeries with smaller incisions, reduced trauma, and faster recovery times, creating new opportunities for alternative care environments.

By application, the preoperative skin preparation market is often superficially viewed as a single, uniform category. However, a deeper examination reveals that the specific surgical indication plays a critical role in determining the chemical formulations used, leaving no room for error due to the high stakes involved in infection prevention. Each type of surgery demands tailored skin preparations that effectively target the unique microbial risks associated with the procedure, ensuring optimal patient safety and clinical outcomes. This nuanced approach underscores the complexity of the market and highlights why different surgical segments exhibit varied demand patterns.

Segment Breakdown

By Product Type

  • Chlorhexidine-based Products
  • Povidone-iodine Solutions
  • Alcohol-based Preparations
  • Antiseptic Wipes
  • Other Skin Preparation Products

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Home Healthcare Providers
  • Research Laboratories

By Application Area

  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Cosmetic Surgery
  • Other Surgical Procedures

By Formulation Type

  • Aqueous Solutions
  • Foams
  • Gels
  • Sprays
  • Pre-soaked Wipes

By Distribution Channel

  • Direct Sales
  • Pharmacies
  • Online Retail
  • Medical Supply Stores
  • Distributors

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • In 2026, North America continues to serve as the cornerstone of the global textile winding machine market, capturing over 40% of total global revenues. This dominant market position reflects the region's advanced manufacturing capabilities, strong industrial infrastructure, and a robust demand for high-quality textile machinery across various sectors. The United States, as the largest economy within North America, plays a particularly pivotal role due to its sizeable textile production and strict regulatory landscape, which together create a lucrative but challenging environment for market participants.
  • A major factor driving the attractiveness and complexity of the US market is its uniquely punitive regulatory and reimbursement framework, particularly in the healthcare segment, where subsea well access systems and related technologies are also critical. The Centers for Medicare & Medicaid Services (CMS) has adopted stringent policies that classify many surgical site infections (SSIs) as "Never Events" or Hospital-Acquired Conditions (HACs). This classification has profound implications for hospitals and healthcare providers, as it directly affects reimbursement practices. Specifically, if a patient develops an SSI following surgery, CMS refuses to cover the costs associated with corrective treatments.

Leading Market Participants

  • 3M
  • B. Braun Melsungen
  • Baxter International
  • Betadine (Johnson & Johnson)
  • DuPont
  • Ecolab
  • Essity
  • GAMA Healthcare
  • Hibiclens (Molnlycke Health Care)
  • Kimberly-Clark
  • Medline Industries
  • Precept Medical Products
  • Smith & Nephew
  • SurgiCare
  • Theradome
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Preoperative Skin Preparation Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Preoperative Skin Preparation Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material & Active Ingredient Sourcing
    • 3.1.2. Formulation & Manufacturing
    • 3.1.3. Distribution & Supply Chain Management
    • 3.1.4. End-User Consumption & Clinical Application
  • 3.2. Industry Outlook
    • 3.2.1. Ten Common Skin Conditions with Treatment Options[PY1.1]
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Product Type

Chapter 4. Global Preoperative Skin Preparation Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Preoperative Skin Preparation Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Chlorhexidine-based Products
        • 5.2.1.1.2. Povidone-iodine Solutions
        • 5.2.1.1.3. Alcohol-based Preparations
        • 5.2.1.1.4. Antiseptic Wipes
        • 5.2.1.1.5. Other Skin Preparation Products
    • 5.2.2. By Formulation
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Aqueous Solutions
        • 5.2.2.1.2. Foams
        • 5.2.2.1.3. Gels
        • 5.2.2.1.4. Sprays
        • 5.2.2.1.5. Pre-soaked Wipes
    • 5.2.3. By Application Area
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. General Surgery
        • 5.2.3.1.2. Orthopedic Surgery
        • 5.2.3.1.3. Cardiovascular Surgery
        • 5.2.3.1.4. Cosmetic Surgery
        • 5.2.3.1.5. Other Surgical Procedures
    • 5.2.4. By End User
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Hospitals
        • 5.2.4.1.2. Ambulatory Surgical Centers
        • 5.2.4.1.3. Specialized Clinics
        • 5.2.4.1.4. Home Healthcare Providers
        • 5.2.4.1.5. Research Laboratories
    • 5.2.5. By Distribution Channel
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Direct Sales
        • 5.2.5.1.2. Pharmacies
        • 5.2.5.1.3. Online Retail
        • 5.2.5.1.4. Medical Supply Stores
        • 5.2.5.1.5. Distributors
    • 5.2.6. By Region
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. North America
          • 5.2.6.1.1.1. The U.S.
          • 5.2.6.1.1.2. Canada
          • 5.2.6.1.1.3. Mexico
        • 5.2.6.1.2. Europe
          • 5.2.6.1.2.1. Western Europe
            • 5.2.6.1.2.1.1. The UK
            • 5.2.6.1.2.1.2. Germany
            • 5.2.6.1.2.1.3. France
            • 5.2.6.1.2.1.4. Italy
            • 5.2.6.1.2.1.5. Spain
            • 5.2.6.1.2.1.6. Rest of Western Europe
          • 5.2.6.1.2.2. Eastern Europe
            • 5.2.6.1.2.2.1. Poland
            • 5.2.6.1.2.2.2. Russia
            • 5.2.6.1.2.2.3. Rest of Eastern Europe
        • 5.2.6.1.3. Asia Pacific
          • 5.2.6.1.3.1. China
          • 5.2.6.1.3.2. India
          • 5.2.6.1.3.3. Japan
          • 5.2.6.1.3.4. South Korea
          • 5.2.6.1.3.5. Australia & New Zealand
          • 5.2.6.1.3.6. ASEAN
              • 5.2.6.1.3.6.1.1. Indonesia
              • 5.2.6.1.3.6.1.2. Malaysia
              • 5.2.6.1.3.6.1.3. Thailand
              • 5.2.6.1.3.6.1.4. Singapore
              • 5.2.6.1.3.6.1.5. Rest of ASEAN
          • 5.2.6.1.3.7. Rest of Asia Pacific
        • 5.2.6.1.4. Middle East & Africa
          • 5.2.6.1.4.1. UAE
          • 5.2.6.1.4.2. Saudi Arabia
          • 5.2.6.1.4.3. South Africa
          • 5.2.6.1.4.4. Rest of MEA
        • 5.2.6.1.5. South America
          • 5.2.6.1.5.1. Argentina
          • 5.2.6.1.5.2. Brazil
          • 5.2.6.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Product Type
      • 6.2.1.2. By Formulation
      • 6.2.1.3. By Application Area
      • 6.2.1.4. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Product Type
      • 7.2.1.2. By Formulation
      • 7.2.1.3. By Application Area
      • 7.2.1.4. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Product Type
      • 8.2.1.2. By Formulation
      • 8.2.1.3. By Application Area
      • 8.2.1.4. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Product Type
      • 9.2.1.2. By Formulation
      • 9.2.1.3. By Application Area
      • 9.2.1.4. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Product Type
      • 10.2.1.2. By Formulation
      • 10.2.1.3. By Application Area
      • 10.2.1.4. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. 3M
  • 11.2. B. Braun Melsungen
  • 11.3. Baxter International
  • 11.4. Betadine (Johnson & Johnson)
  • 11.5. DuPont
  • 11.6. Ecolab
  • 11.7. Essity
  • 11.8. GAMA Healthcare
  • 11.9. Hibiclens (Molnlycke Health Care)
  • 11.10. Kimberly-Clark
  • 11.11. Medline Industries
  • 11.12. Precept Medical Products
  • 11.13. Smith & Nephew
  • 11.14. SurgiCare
  • 11.15. Theradome

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators